Oral micronutrient supplementation showed no benefit on geographic atrophy lesion growth among a patient group from the OAKS and DERBY trials, according to a speaker ...
Aflibercept 8 mg every 12 or 16 weeks provides visual and anatomic gains in patients with polypoidal choroidal vasculopathy.